Eli Lilly Raises 2013 Guidance After Q2 Sales Rise

July 24 (Bloomberg) -- Eli Lilly & Co., the maker of the antidepressant Cymbalta and diabetes treatment Humalog, raised its full-year guidance after second-quarter sales grew faster than expected and cost-cutting programs took effect. Olivia Sterns reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)
NFL Upholds Four-Game Suspension of Tom Brady
19:23 - Tom Brady, the reigning Super Bowl MVP, will miss the first four games of the NFL regular season after commissioner Roger Goodell rejected his appeal of the league discipline imposed in May for his involvement in the New England Patriots’ deflated-ball controversy. Bloomberg's Scarlet Fu reports on "Bloomberg Markets." (Source: Bloomberg)
  • Intel, Micron Introduce Faster Class of Memory Chips
  • Baidu Plunges Most Since 2008 After Outlook Falls Short
  • Why the SAT, ACT Are No Longer Required for Many Colleges